These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 26512875)
1. Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models. Ligat L; Saint-Laurent N; El-Mrani A; Gigoux V; Al Saati T; Tomasini R; Nigri J; Dejean S; Pont F; Baer R; Guillermet-Guibert J; Cordelier P; Lopez F; Dufresne M Br J Cancer; 2015 Dec; 113(11):1590-8. PubMed ID: 26512875 [TBL] [Abstract][Full Text] [Related]
2. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma. LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219 [TBL] [Abstract][Full Text] [Related]
3. Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats. Wen S; Li Z; Feng J; Bai J; Lin X; Huang H Cancer Sci; 2016 Jun; 107(6):836-45. PubMed ID: 27019331 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807 [TBL] [Abstract][Full Text] [Related]
5. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma. Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400 [TBL] [Abstract][Full Text] [Related]
6. Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression. Hutchings D; Waters KM; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Wood LD; Hruban RH Am J Surg Pathol; 2018 Nov; 42(11):1556-1561. PubMed ID: 30212393 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230 [TBL] [Abstract][Full Text] [Related]
8. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models. Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer? Haugk B Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068 [TBL] [Abstract][Full Text] [Related]
10. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. Cruz-Monserrate Z; Abd-Elgaliel WR; Grote T; Deng D; Ji B; Arumugam T; Wang H; Tung CH; Logsdon CD Gut; 2012 Sep; 61(9):1315-22. PubMed ID: 22068166 [TBL] [Abstract][Full Text] [Related]
11. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. Grüner BM; Hahne H; Mazur PK; Trajkovic-Arsic M; Maier S; Esposito I; Kalideris E; Michalski CW; Kleeff J; Rauser S; Schmid RM; Küster B; Walch A; Siveke JT PLoS One; 2012; 7(6):e39424. PubMed ID: 22761793 [TBL] [Abstract][Full Text] [Related]
12. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419 [TBL] [Abstract][Full Text] [Related]
13. [New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis]. Esposito I; Konukiewitz B; Schlitter AM; Klöppel G Pathologe; 2012 Nov; 33 Suppl 2():189-93. PubMed ID: 23011021 [TBL] [Abstract][Full Text] [Related]
14. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia. Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934 [TBL] [Abstract][Full Text] [Related]
16. Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment. Esposito I; Seiler C; Bergmann F; Kleeff J; Friess H; Schirmacher P Pancreas; 2007 Oct; 35(3):212-7. PubMed ID: 17895840 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags. Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339 [TBL] [Abstract][Full Text] [Related]
18. The Prevalence and Clinicopathological Characteristics of High-Grade Pancreatic Intraepithelial Neoplasia: Autopsy Study Evaluating the Entire Pancreatic Parenchyma. Matsuda Y; Furukawa T; Yachida S; Nishimura M; Seki A; Nonaka K; Aida J; Takubo K; Ishiwata T; Kimura W; Arai T; Mino-Kenudson M Pancreas; 2017; 46(5):658-664. PubMed ID: 28196020 [TBL] [Abstract][Full Text] [Related]
19. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer. Waldmann J; Fendrich V; Reichert M; Hecker A; Bartsch DK; Padberg W; Holler JPN J Surg Res; 2018 Mar; 223():230-236. PubMed ID: 29433879 [TBL] [Abstract][Full Text] [Related]
20. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling. Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]